Enzyme immunoassays for the detection of chlamydial antigens are commonly used to diagnose Chlamydia trachomatis infection. As is true for ail nonculture methods, the specificities of these tests are a concern. A confirmatory blocking assay (Abbott Laboratories, North Chicago, Ill.) was evaluated at four sexually transmitted disease test sites. This assay is designed to confirm true-positive Chlamydiazyme (CZ) specimens and to identify false-positive CZ reactions caused by cross-reacting bacteria. Cervical specimens were collected from 2,891 women. Chlamydia prevalence by tissue culture (TC) was 9.2% (266 of 2,891 specimens). Compared with TC, the sensitivity and specificity of CZ were 78.9% (210 of 266 specimens) and 98.2% (2,577 of 2,625 specimens), respectively. There were 48 CZ false-positive reactions. The direct fluorescent-antibody test (DFA) was positive for 31 of 48 false-positive reactions, indicating culture misses. Thus, when the standard was both TC and DFA, CZ sensitivity was 81.1% and CZ specificity was 99.3%. Of the 17 CZ-positive patients who were negative by both TC and DFA, 3 were negative on repeat CZ and Il of 14 were identified as false positive by the confirmatory assay. The confirmatory test was positive for CZ-positive women who were positive by TC or DFA. Use of the confirmatory test, which increased the specificity to 99.9%, would increase confidence in positive CZ results and make the test more useful for screening populations with a low prevalence of C. trachomatis infection.
The "gold standard" for identification of Chlamydia trachomatis is tissue culture (TC) isolation of the agent (11) . However, this is a time-consuming, labor-intensive, and relatively costly technique. Direct antigen detection methods provide a rapid and less expensive alternative, and many laboratories now test for chlamydia by enzyme immunosorbent assay (EIA). Of the commercially available EIA kits, Chlamydiazyme (CZ; Abbott Laboratories, North Chicago, 111.) is the most widely used.
A major limitation of the CZ assay in previous studies of urogenital samples has been its reported specificity of 88.6 to 97.5% when it is compared with the culture method (1, 3, 6, 15) . These data suggest that EIA should be used mainly in populations with a high prevalence of C. trachomatis infections and not in low-risk populations, in whom the predictive value of positive tests is lower. However, a large reservoir of chlamydial infections is found in these low-risk populations. Clinically inapparent infections are common in both men and women (14, 16) . If the problem of nonspecificity and low predictive value of a positive test could be solved, then EIA could be used as a screening test in low-risk populations.
False-positive reactions can occur because TC is <100% sensitive (12) . This is a major problem in evaluating nonculture diagnostic tests. The use of TC as the reference method makes it difficult to establish conclusively which falsepositive reactions are (2, 9) . In a true-positive CZ assay, the antibody reacts with chlamydial lipopolysaccharide (LPS) epitopes. However, chlamydial LPS has at least two antigenic sites; one is shared with the LPS of other bacteria, and the other is apparently chlamydia specific. To distinguish between these reactions, a confirmatory assay has been developed. In this assay, the monoclonal antibody reacts with the chlamydia-specific LPS epitope and blocks the specific reactivity of the CZ antibody. However, the binding of cross-reactive bacteria is not blocked.
We collected cervical samples from patients attending four sexually transmitted disease clinics and tested positive EIA specimens with the Abbott confirmatory assay. The validity of the assay was confirmed by comparing it with TC isolation, DFA smear, and cytospin-fluorescent-antibody (FA) staining of discrepant specimens by the CZ assay.
MATERIALS AND METHODS
Patient population. A total of 2,891 cervical specimens were collected from women attending four sexually transmitted disease clinics (in San Francisco, Seattle, Chicago, and London). The patients screened were females at moderate to high risk of contracting C. trachomatis infections.
The majority of patients were under 30 years old and were often symptomatic.
We tested only cervical specimens. The majority of EIAs are done with such specimens. Most men with symptomatic urethritis are treated empirically or on the basis of a Gram stain of urethral discharge. Screening of asymptomatic men is not a routine procedure. However, screening of women, in some settings, is standard, and the specificity of nonculture diagnostic tests is an important determinant in the application of these tests.
Specimen collection. Ail specimens were collected from the endocervical canal. Briefly, the exocervix was cleaned of excess mucus and exudate. A swab or cytobrush was then rotated against the wall and removed, avoiding contact with any vaginal surface. The order of sampling for TC and the CZ assay was randomized. A third specimen for DFA was collected from all patients seen at San Francisco and Seattle. All specimens for the CZ assay and TC were collected with swabs. For DFA samples collected with a swab or cytobrush were tested.
For TC (San Francisco), the swab was placed into transport medium (2.0 ml of Eagle minimal essential medium in Earle salts containing 10% fetal bovine serum, 1% L-glutamine [200 nM solution], 10 ,ug of gentamicin per ml, 100 ,ug of vancomycin per ml, 10 U of mycostatin per ml, and 0.003 mM of glucose per ml). The laboratories in Seattle, Chicago, and London used sucrose phosphate medium with antibiotics for transport (10) . Specimens were refrigerated (4°C) until they were inoculated into cells. For DFA, the 8-mm-diameter well of a MicroTrak (Syva Co., Palo Alto, Calif.) slide was evenly covered with the sample collected with a cytobrush or swab. The smear was air dried, fixed by flooding it with methanol, and air dried again. The cotton swab for the CZ assay was placed into the CZ transport tube (containing a storage reagent and a biostatic substance to retard growth of organisms). For all test comparisons, each procedure was performed independently, with technicians being unaware of the other results.
TC procedure. By using a modification of the procedure of Ripa and Mardh (8), specimens were inoculated onto McCoy cells within 72 h of collection. In San Francisco and London, 1-dram (3.7-ml) shell vials, an FA stain, and a blind pass were used. In Seattle and Chicago, microtiter plates and an FA stain were used at first pass. All monolayers were stained with a culture confirmation reagent (Syva Co.). Positive cultures contained typical apple green inclusions.
CZ assay procedure. The CZ assay was done according to the instructions of the manufacturer (Abbott Laboratories). Briefly, 200 ,ul of vortexed specimens and controls were placed into reaction trays. For the CZ assay, we used three 1-h incubations at 37°C in a H20 bath with (i) treated beads, (ii) rabbit antibody to C. trachomatis, and (iii) horseradish peroxidase-conjugated antibody to rabbit immunoglobulin G. After each incubation, the beads were washed with distilled H20. For color development, the beads were transferred to tubes, and 300 pul of o-phenylenediamine was added. Tubes were incubated at room temperature for 30 min, and then the reaction was stopped with 1 ml of 1 N sulfuric acid. The optical densities (ODs) of the reactions were measured with a spectrophotometer (Quantum II) at A492. CZ-positive specimens were saved at 4°C for retesting.
CZ confirmatory assay procedure. The monoclonal antibody used in the confirmatory assay was produced by Abbott Laboratories from mouse ascitic fluid. It was raised against C. trachomatis 434, an L2 serovar.
The monoclonal antibody was added to rabbit anti-C. Resolution of false-positive results. (i) MicroTrak procedure. Smears were stained and read by using a C. trachomatis direct specimen test (MicroTrak; Syva Co.). The instructions of the manufacturer were followed. Ail specimens were screened by microscopy at a magnification of x400, and every field was scanned. Ail positive smears were confirmed at x1,000 and had 10 or more smooth, evenly fluorescing, bright apple green disks, consistent with chlamydial elementary bodies.
(ià) Reculture procedure. After inoculation, the original TC specimens were frozen at -80°C. These samples were thawed, and reisolation was attempted by using the same methods described above. This procedure was performed only in San Francisco.
(ii) Cytospin and FA stain on CZ samples. A 0.25-ml sample of the remaining CZ specimen was diluted with 0.75 ml of phosphate-buffered saline. Tubes were centrifuged at 3,000 x g for 20 min. The supernatant was aspirated, leaving 0.25 ml in the tube. A 30-pul sample of the resuspended pellet was air dried onto a glass slide. Procedures for DFA staining were then followed as described above.
RESULTS
Blocking reaction at various concentrations. The blocking of CZ by the confirmatory antibody at various concentrations of serovar L2 (strain 434) from 103 to 106 elementary VOL. 28, 1990 on November 6, 2017 by guest http://jcm.asm.org/ Downloaded from Table 2 shows the results for all C. trachomatis serovars, various Chlamydia psittaci serovars, and Chlamydia pneumoniae in the regular CZ and confirmatory assays. The chlamydial LPS is a genus-specific antigen. Thus, as expected, all serovars within the three chlamydial species that were tested were detected in the CZ assay. AUl ODs were reduced by at least 95% compared with the ODs in the unblocked assay.
Clinical study. The overall prevalence of C. trachomatis among the women tested was 9.2% (266 of 2,891 specimens) by culture (Table 3 ). The CZ assay was positive for 210 of 266 culture-positive specimens (sensitivity, 78.9%) and 48 of 2,625 culture-negative specimens (specificity, 98.2%). How- (11) . In some of our previous evaluations (7, 13) , TC had a sensitivity of 76% in a population with trachoma (conjunctiva samples) and a sensitivity of 69% in a sexually transmitted disease clinic (cervical samples) when a calcium alginate swab was used as a collection device. In the latter study, we were able to increase TC sensitivity to 100% by using the cytobrush. Although the cytobrush was not used in this study, we did have a high TC sensitivity (90%). Lefebvre et al. (5) found that in an asymptomatic population, 9 of 15 apparent falsepositive CZ samples were, in fact, true positives as demonstrated by a reculture that yielded a positive isolation. In considering these data, the specificity increased from 96.8 to 98%. Upon our reevaluation of the performance profile of CZ (Table 3) (4) showed that repetition of discrepant, duplicate specimens tested by the CZ assay is helpful in defining false-positive samples. Assays were repeated for paired samples which had positive and negative CZ assay results. A false-positive specimen retested as negative and a true-positive specimen retested as positive. Applying this rule, we would have misidentified 14 false-positive samples as true-positive samples. Samples that were positive because of cross-reacting bacteria would still retest as positive. Only 3 of our 17 apparent false-positive samples would, after retesting, be considered true false-positive samples. We chose to accept both reproducibility of the positive signal and blocking in the confirmatory test as criteria for positivity.
This study has shown that the CZ assay is appropriate for screening populations with a low prevalence of C. trachomatis infections. Some infections will be missed, as sensitivity was -80%. False-positive specimens should not be a problem, however. With a CZ assay specificity of 99.9% with the use of the confirmatory assay, clinicians can have confidence in a positive CZ assay result.
